Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(100)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Jul 10, 2024 3:21am
RE:Any concerns?
A huge market for CBD if the studies on opiate withdrawal with CBD are successful! THANK YOU for sharing
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jul 09, 2024 8:26pm
Any concerns?
https://www.msn.com/en-ca/money/topstories/the-threat-of-litigation-looms-as-purdue-pharma-returns-to-settlement-talks/ar-BB1pHgBh?ocid=msedgntp&pc=U531&cvid=be11dc21e63343cb9293d4f37493af93
...more
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Comment by
Starkicker
on Jul 09, 2024 2:05pm
RE:RE:Strong product position....
Don't forget that rock solid balance sheet!
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jul 09, 2024 12:09pm
Dave, as a non-doctor, non-scientist, you should
still be made aware of the inflamatory fighting capabilities of inhaled CBD into the lung structure of humans. Rather than wasting your time promoting your deal with Remidose to entertain
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Jul 08, 2024 1:20pm
RE:The stock price will not sustain another
I am expecting a very little positiv EBITDA that's about it. Little bit of invrease in the revenue and gros profit with a reduction of the Administration from ovr 4 milliond to 1 million.
(45)
•••
piduks
X
View Profile
View Bullboard History
Post by
piduks
on Jul 08, 2024 1:09pm
The stock price will not sustain another
failure when earnings announced in mid August from Q2 activity. Will it go to $.01 ?
(64)
•••
corvette67
X
View Profile
View Bullboard History
Comment by
corvette67
on Jul 08, 2024 12:20pm
RE:Strong product position....
Its diversified revenue stream and strong Canadian base have got it up to $.07. LOL GLTA
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Jul 08, 2024 12:16pm
Last calendar about rescheduling from 1 to 3
Timeline for Implementation Key dates include: May 21, 2024: Publication of the proposed rescheduling draft ruling (PRDR) in the Federal Register and the start of a 60-day public comment period
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Jul 08, 2024 10:43am
TD
is totally controling the market today as of lately.
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Jul 08, 2024 10:41am
Research and development
Pharmaceutical and Business to Business (“B2B”): This stream includes the production and sale of bulk cannabis concentrate based products such as dronabinol, concentrate, distillate and isolate to
...more
(731)
•••
prone
X
View Profile
View Bullboard History
Post by
prone
on Jul 08, 2024 8:19am
Strong product position....
Specializing in the research-driven development and manufacturing of cannabis API, the company has diversified its revenue portfolio and operates with a strong Canadian base. Their CBD dominant oil
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Jul 07, 2024 1:49pm
RE:Headset data.
It is positive but that shows very small revenue.
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Jul 05, 2024 12:38pm
RE:Headset data.
Appears positive certainly. What comes of the positivity, who knows.
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Post by
alleyesonme
on Jul 05, 2024 11:43am
Headset data.
https://www.headset.io/brands/medipharm-labs
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >